CN101318964B - 盐酸伊立替康新晶型及其制备方法 - Google Patents
盐酸伊立替康新晶型及其制备方法 Download PDFInfo
- Publication number
- CN101318964B CN101318964B CN2007100417382A CN200710041738A CN101318964B CN 101318964 B CN101318964 B CN 101318964B CN 2007100417382 A CN2007100417382 A CN 2007100417382A CN 200710041738 A CN200710041738 A CN 200710041738A CN 101318964 B CN101318964 B CN 101318964B
- Authority
- CN
- China
- Prior art keywords
- crystallization
- degrees
- raw material
- mentioned steps
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Angle(°2θ) | Relative Intensity(%) |
7.60 | 47.9 |
8.30 | 33.4 |
9.55 | 36.9 |
11.00 | 100.0 |
12.40 | 88.1 |
Angle(°2θ) | Relative Intensity(%) |
9.15 | 100.0 |
10.00 | 72.6 |
11.8 | 51.6 |
12.20 | 21.8 |
13.00 | 31.5 |
13.40 | 22.6 |
Angle(°20) | Relative Intensity(%) |
7.80 | 100.0 |
9.96 | 57.7 |
13.28 | 21.9 |
15.62 | 27.9 |
19.98 | 20.3 |
20.36 | 28.6 |
22.34 | 27.1 |
22.66 | 17.1 |
26.60 | 24.9 |
30.18 | 18.0 |
Claims (13)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100417382A CN101318964B (zh) | 2007-06-07 | 2007-06-07 | 盐酸伊立替康新晶型及其制备方法 |
PCT/CN2007/003071 WO2008148260A1 (fr) | 2007-06-07 | 2007-10-29 | Nouvelle forme cristalline d'hydrochlorure d'irinotécan et sa préparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100417382A CN101318964B (zh) | 2007-06-07 | 2007-06-07 | 盐酸伊立替康新晶型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101318964A CN101318964A (zh) | 2008-12-10 |
CN101318964B true CN101318964B (zh) | 2010-12-15 |
Family
ID=40093140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100417382A Active CN101318964B (zh) | 2007-06-07 | 2007-06-07 | 盐酸伊立替康新晶型及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101318964B (zh) |
WO (1) | WO2008148260A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101659667B (zh) * | 2009-09-07 | 2011-11-02 | 重庆泰濠制药有限公司 | 一种盐酸伊立替康的纯化方法 |
US8546573B2 (en) | 2009-11-18 | 2013-10-01 | Cadila Healthcare Limited | Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate |
CN102311443B (zh) * | 2011-08-24 | 2014-07-16 | 上海北卡医药技术有限公司 | 盐酸伊立替康的新晶型及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004076460A1 (ja) * | 2003-02-25 | 2004-09-10 | Kabushiki Kaisha Yakult Honsha | イリノテカン塩酸塩の結晶多形の製造方法 |
CN1642958A (zh) * | 2002-03-01 | 2005-07-20 | 法玛西雅意大利公司 | 盐酸伊立替康的结晶多晶型物 |
WO2007035709A2 (en) * | 2005-09-20 | 2007-03-29 | Scinopharm Singapore Pte, Ltd. | Novel crystal forms of irinotecan hydrochloride |
-
2007
- 2007-06-07 CN CN2007100417382A patent/CN101318964B/zh active Active
- 2007-10-29 WO PCT/CN2007/003071 patent/WO2008148260A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1642958A (zh) * | 2002-03-01 | 2005-07-20 | 法玛西雅意大利公司 | 盐酸伊立替康的结晶多晶型物 |
WO2004076460A1 (ja) * | 2003-02-25 | 2004-09-10 | Kabushiki Kaisha Yakult Honsha | イリノテカン塩酸塩の結晶多形の製造方法 |
WO2007035709A2 (en) * | 2005-09-20 | 2007-03-29 | Scinopharm Singapore Pte, Ltd. | Novel crystal forms of irinotecan hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
CN101318964A (zh) | 2008-12-10 |
WO2008148260A1 (fr) | 2008-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9199970B2 (en) | 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile crystalline polymorph and production method therefor | |
US7956048B2 (en) | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | |
US20070203146A1 (en) | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | |
US20140031352A1 (en) | Solid forms of tyrosine kinase inhibitors, process for the preparation and their pharmaceutical composition thereof | |
WO2017008773A1 (en) | Crystalline forms of obeticholic acid | |
CN101318964B (zh) | 盐酸伊立替康新晶型及其制备方法 | |
JP2005298424A (ja) | エパルレスタット結晶の製造方法 | |
US11091494B2 (en) | Crystal form of acalabrutinib and preparation method and use thereof | |
US10301344B2 (en) | L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof | |
US8013158B2 (en) | Crystalline forms of topotecan hydrochloride and processes for making the same | |
EP3272734A1 (en) | Ahu377 crystal form, preparation method and use thereof | |
US10781160B1 (en) | Hexadecyl Treprostinil crystals and methods for preparation thereof | |
US20180344854A1 (en) | Supersaturated compositions of benzimidazole compounds | |
CN103113348B (zh) | 枸地氯雷他定的假多晶型及其制备方法 | |
KR20230062917A (ko) | 피마살탄 일수화물 b형 결정다형 및 그 제조방법 | |
CN115974803A (zh) | 一种普赛莫德的晶型及其制备方法和用途 | |
TW202227387A (zh) | 單水合曲前列環素晶體及其製備方法 | |
KR20230062916A (ko) | 피마살탄 무수물 a형 결정다형 및 그 제조방법 | |
CN105037341A (zh) | 阿齐沙坦醇铵晶型及其制备方法 | |
TWI592397B (zh) | 卡維地洛硫酸鹽的結晶、其製備方法及其在醫藥上的應用 | |
CN116063300A (zh) | 一种含氮化合物的盐酸盐 | |
CN117003689A (zh) | 一种碘解磷定的晶型及其制备方法 | |
CN114805216A (zh) | 奥拉帕利晶型及其制备方法 | |
WO2018162393A1 (en) | Vinpocetine co-crystals and preparation process thereof | |
CN103373952A (zh) | 硫酸卡维地洛的新晶型 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI XIDI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: DISAINO MEDICINE DEVELOPMENT CO., LTD, SHANGHAI Effective date: 20110214 Free format text: FORMER OWNER: SHANGHAI DISAINUO CHEMICAL PHARMACEUTICAL CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 NO.1479, ZHANGHENG ROAD, ZHANGJIANG HIGH TECHNOLOGY PARK, PUDONG NEWDISTRICT, SHANGHAI TO: 201203 BUILDING 9, NO.1999, ZHANGHENG ROAD, ZHANGJIANG HIGH TECHNOLOGY PARK, PUDONG NEW DISTRICT, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110214 Address after: 201203, building 1999, No. 9 Zhang Heng Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee after: Shanghai Xidi Pharmaceutical Co., Ltd. Address before: 201203 Zhang Heng road Shanghai, Pudong New Area Zhangjiang hi tech Park No. 1479 Co-patentee before: Shanghai Disainuo Chemical Pharmaceutical Co., Ltd. Patentee before: Disaino Medicine Development Co., Ltd, Shanghai |
|
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI CHUANGNUO PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHANGHAI XIDI PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 201203, building 1999, No. 9 Zhang Heng Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee after: Shanghai Chuangnuo Pharmaceutical Co., Ltd. Address before: 201203, building 1999, No. 9 Zhang Heng Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee before: Shanghai Xidi Pharmaceutical Co., Ltd. |